Zevenbergen Capital Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-469,407
| Closed | -$35.7M | – | 85 |
|
|
2020
Q3 | $35.7M | Sell |
469,407
-192,223
| -29% | -$14.6M | 0.72% | 32 |
|
|
2020
Q2 | $81.6M | Buy |
661,630
+18,505
| +3% | +$2.28M | 1.95% | 18 |
|
|
2020
Q1 | $54.3M | Buy |
643,125
+28,415
| +5% | +$2.4M | 2.05% | 20 |
|
|
2019
Q4 | $52M | Buy |
614,710
+24,370
| +4% | +$2.06M | 1.93% | 20 |
|
|
2019
Q3 | $39.8M | Sell |
590,340
-47,855
| -7% | -$3.23M | 1.52% | 24 |
|
|
2019
Q2 | $54.7M | Buy |
638,195
+165,445
| +35% | +$14.2M | 1.79% | 21 |
|
|
2019
Q1 | $42M | Buy |
472,750
+47,125
| +11% | +$4.19M | 1.49% | 28 |
|
|
2018
Q4 | $36.2M | Buy |
425,625
+37,750
| +10% | +$3.21M | 1.58% | 27 |
|
|
2018
Q3 | $37.6M | Sell |
387,875
-10,100
| -3% | -$979K | 1.19% | 34 |
|
|
2018
Q2 | $37.5M | Buy |
397,975
+133,070
| +50% | +$12.5M | 1.25% | 31 |
|
|
2018
Q1 | $21.5M | Hold |
264,905
| – | – | 0.83% | 34 |
|
|
2017
Q4 | $23.6M | Sell |
264,905
-2,440
| -0.9% | -$218K | 0.98% | 33 |
|
|
2017
Q3 | $24.9M | Sell |
267,345
-16,340
| -6% | -$1.52M | 1.08% | 33 |
|
|
2017
Q2 | $25.8M | Sell |
283,685
-26,674
| -9% | -$2.42M | 1.12% | 32 |
|
|
2017
Q1 | $27.2M | Sell |
310,359
-38,835
| -11% | -$3.41M | 1.25% | 32 |
|
|
2016
Q4 | $28.9M | Sell |
349,194
-60,705
| -15% | -$5.03M | 1.36% | 31 |
|
|
2016
Q3 | $37.9M | Sell |
409,899
-46,060
| -10% | -$4.26M | 1.56% | 27 |
|
|
2016
Q2 | $35.5M | Sell |
455,959
-4,250
| -0.9% | -$331K | 1.66% | 28 |
|
|
2016
Q1 | $38M | Buy |
460,209
+2,452
| +0.5% | +$202K | 1.72% | 22 |
|
|
2015
Q4 | $48M | Buy |
457,757
+44,200
| +11% | +$4.63M | 1.95% | 24 |
|
|
2015
Q3 | $43.6M | Sell |
413,557
-2,375
| -0.6% | -$250K | 1.87% | 27 |
|
|
2015
Q2 | $56.9M | Buy |
415,932
+46,150
| +12% | +$6.31M | 2.21% | 22 |
|
|
2015
Q1 | $46.1M | Buy |
369,782
+345,705
| +1,436% | +$43.1M | 1.93% | 25 |
|
|
2014
Q4 | $2.18M | Buy |
+24,077
| New | +$2.18M | 0.09% | 48 |
|